Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Aaron, Pham"'
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
Purpose This article highlights one academic medical center’s effort to implement a complete credentialing and privileging (C&P) process for both inpatient and ambulatory clinical pharmacists. Summary The C&P process offers a recognized method to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437b939509078b8731f623a889cad961
https://pubmed.ncbi.nlm.nih.gov/36617182
https://pubmed.ncbi.nlm.nih.gov/36617182
Autor:
Wei Yao, Weiwei Dai, Mohammad Shahnazari, Aaron Pham, Zhiqiang Chen, Haiyan Chen, Min Guan, Nancy E Lane
Publikováno v:
PLoS ONE, Vol 5, Iss 7, p e11410 (2010)
Augmentation of the peak bone mass (PBM) may be one of the most effective interventions to reduce the risk of developing osteoporosis later in life; however treatments to augment PBM are currently limited. Our study evaluated whether a greater PBM co
Externí odkaz:
https://doaj.org/article/be00cb330d9147798888044dafa9e095
Autor:
Scott F Geller, Karen I Guerin, Meike Visel, Aaron Pham, Edwin S Lee, Amiel A Dror, Karen B Avraham, Toshinori Hayashi, Catherine A Ray, Thomas A Reh, Olivia Bermingham-McDonogh, William J Triffo, Shaowen Bao, Juha Isosomppi, Hanna Västinsalo, Eeva-Marja Sankila, John G Flannery
Publikováno v:
PLoS Genetics, Vol 5, Iss 8, p e1000607 (2009)
Mutations in the CLRN1 gene cause Usher syndrome type 3 (USH3), a human disease characterized by progressive blindness and deafness. Clarin 1, the protein product of CLRN1, is a four-transmembrane protein predicted to be associated with ribbon synaps
Externí odkaz:
https://doaj.org/article/5b0b5b895c4640a499371880eb763eef
Publikováno v:
Journal of Comparative Neurology. 523:545-564
Protocols for characterizing cellular phenotypes commonly use chemical fixatives to preserve anatomical features, mechanically stabilize tissue, and stop physiological responses. Formaldehyde, diluted in either phosphate-buffered saline or phosphate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c67ca346fb7a2699ee686ca5d1bd8ee2
https://doi.org/10.1002/cne.23689
https://doi.org/10.1002/cne.23689
Autor:
Cheryl Busse, Robert O. Ritchie, Elizabeth A. Zimmermann, Aaron Pham, Wei Yao, Nancy E Lane, Zhiqiang Cheng
Publikováno v:
Arthritis & Rheumatism. 58:3485-3497
Objective. Glucocorticoid excess decreases bone mineralization and microarchitecture and leads to reduced bone strength. Both anabolic (parathyroid hormone [PTH]) and antiresorptive agents are used to prevent and treat glucocorticoid-induced bone los
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3509607fbca2a8575eb063595c9db092
https://doi.org/10.1002/art.23954
https://doi.org/10.1002/art.23954
Publikováno v:
The Journal of comparative neurology. 523(4)
Protocols for characterizing cellular phenotypes commonly use chemical fixatives to preserve anatomical features, mechanically stabilize tissue, and stop physiological responses. Formaldehyde, diluted in either phosphate-buffered saline or phosphate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d9daf11c47b80ac4f74ab7d3cf7878d
https://pubmed.ncbi.nlm.nih.gov/25283775
https://pubmed.ncbi.nlm.nih.gov/25283775
Publikováno v:
Neuron. 69(4)
SummaryRetinal degenerative diseases cause photoreceptor loss and often result in remodeling and deafferentation of the inner retina. Fortunately, ganglion cell morphology appears to remain intact long after photoreceptors and distal retinal circuitr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f3ba347643937061c2c4dcfc22e8aad
https://pubmed.ncbi.nlm.nih.gov/21338881
https://pubmed.ncbi.nlm.nih.gov/21338881
Autor:
Zhiqiang Chen, Wei Yao, Nancy E Lane, Min Guan, Mohammad Shahnazari, Weiwei Dai, Aaron Pham, Haiyan Chen
Publikováno v:
PloS one, vol 5, iss 7
PLoS ONE, Vol 5, Iss 7, p e11410 (2010)
PLoS ONE
PLoS One, vol 5, iss 7
PLoS ONE, Vol 5, Iss 7, p e11410 (2010)
PLoS ONE
PLoS One, vol 5, iss 7
Augmentation of the peak bone mass (PBM) may be one of the most effective interventions to reduce the risk of developing osteoporosis later in life; however treatments to augment PBM are currently limited. Our study evaluated whether a greater PBM co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af9d72832d30b9343e72d814694f0e3
https://escholarship.org/uc/item/3hx1973g
https://escholarship.org/uc/item/3hx1973g
Autor:
Thomas A. Reh, Meike Visel, Hanna Västinsalo, Aaron Pham, Toshinori Hayashi, K. Guerin, Juha Isosomppi, Amiel A. Dror, Eeva-Marja Sankila, S.F. Geller, John G. Flannery, W.J. Triffo, Shaowen Bao, Catherine A. Ray, Edwin S. Lee, Karen B. Avraham, Olivia Bermingham-McDonogh
Publikováno v:
PLoS Genetics, Vol 5, Iss 8, p e1000607 (2009)
PLoS genetics, vol 5, iss 8
PLoS Genetics
PLoS genetics, vol 5, iss 8
PLoS Genetics
Mutations in the CLRN1 gene cause Usher syndrome type 3 (USH3), a human disease characterized by progressive blindness and deafness. Clarin 1, the protein product of CLRN1, is a four-transmembrane protein predicted to be associated with ribbon synaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adfe7c40ef48d99354520302cd9df1bf
http://europepmc.org/articles/PMC2719914?pdf=render
http://europepmc.org/articles/PMC2719914?pdf=render
Publikováno v:
Journal of Comparative Neurology. 523:Spc1-Spc1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60f102a08596e7f572bb88b868bf86e7
https://doi.org/10.1002/cne.23737
https://doi.org/10.1002/cne.23737